For over 16 years, we have become the most professional manufacturer in the world, No.1 in China in the methylfolate industry. With strict quality guarantee system, strong brand awareness and high-level after sale service, our company is famous for the business philosophy “Only manufacture and supply premium quality products.”
For the Thanksgiving Day, may you and your family enjoy this holiday full of warm moments and precious memories. At this special moment, Jinkang Pharma also would like to take this opportunity to express our sincere gratitude to all of customers. Thank you for your trust and support
Infertility outpatient reproductive center Decreased men's sperm density, recurrent abortion, etiological diagnosis of complex diseases. The MTHFR C677T genotype increased the risk of male infertility by 2.68 times, and the TT genotype had a 2.96 times higher risk of habitual abortion than the wild type.
Methylenetetrahydrofolate reductase (MTHFR) is one of the key enzymes in the metabolism of folate and homocysteine (Hcy), and is involved in the occurrence of neuropsychiatric diseases such as Alzheimer's disease and depression.
MTHFR genetic defects will affect the body's use of folic acid, causing pregnancy-induced hypertension, spontaneous abortion, fetal neural tube defects, congenital heart disease, cleft lip and palate, etc. Insufficient amount of effectively used folate can lead to birth defects and adverse pregnancy outcomes, but is also a high-risk factor for infant intellectual development, maternal depression, and child autism.
MTHFR genotype causes abnormality of folate metabolism and related disease mechanism
North American health authorities recommend 0.4 mg/day folic acid before conception and throughout pregnancy to reduce the risk of neural tube defects. As usual, there are folic acid and L-Methylfolate for pregnants.
Copyright © 2021 Lianyungang Jinkang Hexin Pharmaceutical Co.,Ltd. All Rights Reserved jinkang-chem